Baseline characteristics and comparison based on initial treatment modality.

Baseline characteristics and comparison based on initial treatment modality.</p

Risk factors for overall survival.

Risk factors for overall survival.</p

Overall survival according to initial treatment modality in hepatocellular carcinoma patients with extrahepatic spread.

Abbreviation: TACE, transarterial chemoembolization.</p

Initial and subsequent treatment according to initial treatment modality.

Initial and subsequent treatment according to initial treatment modality.</p

Overall survival by initial treatment modality (transarterial chemoembolization vs. sorafenib) according to pre-defined subgroups.

Overall survival by initial treatment modality (transarterial chemoembolization vs. sorafenib) according to pre-defined subgroups.</p